Larry Ellison Backs Oxford spinout Wild Bio in 45M round
Briefly

Larry Ellison Backs Oxford spinout Wild Bio in 45M round
"Wild Bio is using AI to better understand the lessons learned over millions of years of evolution encoded in plant genomes,"
"Those insights, combined with precision breeding, have enabled Wild Bio to develop new crop varieties with both higher yields and climate resilience. The ultimate goal is to grow these crops at commercial scale and help provide food security around the world."
Wild Bioscience secured £45 million in Series A funding led by the Ellison Institute of Technology, with participation from Oxford Science Enterprises, Braavos Capital, and the University of Oxford. The investment will support AI-driven genetic discovery and precision breeding to create higher-yield, climate-resilient crop varieties and prepare those varieties for commercial scale. Founded in 2021 by Dr Ross Hendron and Professor Steve Kelly at the University of Oxford, the company deciphers genetic information from wild plant species and uses a proprietary computational biology and AI platform to map plant evolution and identify genetic innovations. Leading projects are in field trials across four countries.
Read at Business Matters
Unable to calculate read time
[
|
]